Lab1636
Lab1636 (Harvard OTD)
New York, United States · Founded 2019 · $100.0M raised
- Headquarters
- New York, New York
- Founded
- 2019
- Business Model
- B2B
- Website
- lab1636.com
- Total Funding
- $100.0M
- Last Round
- $100.0M SeedMar 2019
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Lab1636 is a Harvard-Deerfield translational research company launched in March 2019 to speed biomedical and life-science innovations into treatments. Wholly owned by Deerfield affiliates and led with Harvard Office of Technology Development, it funds university drug-discovery projects from disease biology and target validation through Investigational New Drug proof-of-concept, and can license technologies or back startups built on Harvard science.
Summary
Lab1636 is a Biotech company based in New York, United States, founded in 2019. It has raised $100.0M in total across 1 round, most recently a $100.0M Seed round in Mar 2019. Investors include Deerfield Management.
Funding History
Mar 2019
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Therapeutics company working in drug discovery and development using fungi with genomics approach...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lab1636"><img src="https://indexed.vc/api/badge/company/lab1636" alt="Lab1636 on Indexed.vc" width="260" height="76" /></a>